GetTopicDetailResponse(id=6bf0153924b, topicName=RET突變型, introduction=RET突變型, content=null, image=null, comments=1, allHits=928, url=https://h5.medsci.cn/topic?id=15392, type=0, isShow=1, status=1, isAdmin=null, adminId=1, adminEncryptionId=1eae1, adminName=小M, createdBy=null, createdName=, createdAvatar=, createdTime=Fri May 29 21:19:53 CST 2020, time=2020-05-29, bannerImg=https://img.medsci.cn/202167/1623032167418_5160405.png, bannerImgH5=https://img.medsci.cn/202167/1623032167418_5160405.png, likes=0, followStatus=false, moduleDTOList=null, tagId=98316, tagList=[TagDto(tagId=98316, tagName=RET突變型)], ipAttribution=, topicAdmin=1, lengthMark=0)
[GetTopicListResponse(id=1974500, encodeId=37c619e45003b, content=<a href='/topic/show?id=6bf0153924b' target=_blank style='color:#2F92EE;'>#RET突變型#</a>, objectTitle=RET突變型甲狀腺髓樣癌：selpercatinib的III期臨床試驗(yàn)已開(kāi)始, objectType=article, longId=185522, objectId=448618552283, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=448618552283, replyNumber=0, likeNumber=85, createdTime=2020-07-16, rootId=0, userName=ms9203727104890838, userId=706e2500208, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=448618552283, moduleTitle=RET突變型甲狀腺髓樣癌：selpercatinib的III期臨床試驗(yàn)已開(kāi)始, moduleType=article, hrefUrl=http://ermita.cn/article/show_article.do?id=448618552283)], followStatus=false, userIsMember=false, type=1, lengthMark=0)]
梅斯話題小助手
2020-05-29
